This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Jul;43(7):844-7.

doi: 10.1046/j.1537-2995.2003.00492.x.

How concerned should we be about missing antibodies to low incidence antigens?

George Garratty

PMID: 12823741
DOI: 10.1046/j.1537-2995.2003.00492.x

Review

How concerned should we be about missing antibodies to low incidence antigens?

George Garratty. Transfusion. 2003 Jul.

. 2003 Jul;43(7):844-7.

doi: 10.1046/j.1537-2995.2003.00492.x.

Author

George Garratty

PMID: 12823741
DOI: 10.1046/j.1537-2995.2003.00492.x

No abstract available

PubMed Disclaimer

Comment on

The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matching.
Schonewille H, van Zijl AM, Wijermans PW. Schonewille H, et al. Transfusion. 2003 Jul;43(7):939-44. doi: 10.1046/j.1537-2995.2003.t01-1-00435.x. Transfusion. 2003. PMID: 12823754

Similar articles

Evaluating the clinical significance of blood group alloantibodies that are causing problems in pretransfusion testing.
Garratty G. Garratty G. Vox Sang. 1998;74 Suppl 2:285-90. doi: 10.1111/j.1423-0410.1998.tb05433.x. Vox Sang. 1998. PMID: 9704458 Review. No abstract available.
Antibodies of undetermined significance: nuisance or near miss?
Tormey CA, Hendrickson JE. Tormey CA, et al. Transfusion. 2013 May;53(5):926-8. doi: 10.1111/trf.12147. Transfusion. 2013. PMID: 23659526 No abstract available.
Controversies in transfusion medicine. Prewarmed tests: pro-why, when, and how-not if.
Mallory D. Mallory D. Transfusion. 1995 Mar;35(3):268-70. doi: 10.1046/j.1537-2995.1995.35395184286.x. Transfusion. 1995. PMID: 7878722 No abstract available.
[Irregular agglutinins and the compatibility test: the elements of choice].
Rouger P, Salmon C. Rouger P, et al. Rev Fr Transfus Immunohematol. 1983 Feb;26(1):5-13. doi: 10.1016/s0338-4535(83)80045-2. Rev Fr Transfus Immunohematol. 1983. PMID: 6407087 Review. French. No abstract available.
The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matching.
Schonewille H, van Zijl AM, Wijermans PW. Schonewille H, et al. Transfusion. 2003 Jul;43(7):939-44. doi: 10.1046/j.1537-2995.2003.t01-1-00435.x. Transfusion. 2003. PMID: 12823754

See all similar articles

Cited by

Pathogenesis and mechanisms of antibody-mediated hemolysis.
Flegel WA. Flegel WA. Transfusion. 2015 Jul;55 Suppl 2(0):S47-58. doi: 10.1111/trf.13147. Transfusion. 2015. PMID: 26174897 Free PMC article. Review.
The blood bank "black box" debunked: pretransfusion testing explained.
Yazer MH. Yazer MH. CMAJ. 2006 Jan 3;174(1):29-32. doi: 10.1503/cmaj.050919. CMAJ. 2006. PMID: 16389232 Free PMC article. No abstract available.
Transitioning a multiethnic donor pool from serologic D-negative to molecularly RHD-negative at a hospital-based blood donor service.
Flegel WA, Srivastava K, Caruccio LG, Schmid P, Stiles DA, Bueno MU, Dowling NR, Paige TD, Shrestha S. Flegel WA, et al. J Transl Med. 2025 Jun 19;23(1):686. doi: 10.1186/s12967-025-06716-8. J Transl Med. 2025. PMID: 40537781 Free PMC article.
Fatal Acute Hemolytic Transfusion Reaction due to Anti-Wr^a.
Bahri T, de Bruyn K, Leys R, Weerkamp F. Bahri T, et al. Transfus Med Hemother. 2018 Nov;45(6):438-441. doi: 10.1159/000488863. Epub 2018 Aug 24. Transfus Med Hemother. 2018. PMID: 30574061 Free PMC article.
DEL.
Flegel WA, Wagner FF. Flegel WA, et al. Blood Transfus. 2020 May;18(3):159-162. doi: 10.2450/2020.0296-19. Epub 2020 Mar 17. Blood Transfus. 2020. PMID: 32203009 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley